Literature DB >> 24336334

Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis.

Jing Shi1, Lotte A van de Stadt, E W Nivine Levarht, Tom W J Huizinga, Dörte Hamann, Dirkjan van Schaardenburg, René E M Toes, Leendert A Trouw.   

Abstract

OBJECTIVE: The presence of anti-citrullinated protein antibodies (ACPA) and IgM-rheumatoid factor (IgM-RF) years before the clinical diagnosis of rheumatoid arthritis (RA) suggests they are possibly involved in the pathogenic process underlying RA. In this study, we analysed whether anti-carbamylated protein (anti-CarP) antibodies, a novel autoantibody system against carbamylated proteins, can also be detected in healthy individuals before they developed RA.
METHODS: Multiple sera from asymptomatic blood donors prior to the onset of their RA symptoms and sera from age-matched and sex-matched controls were tested for the presence of antibodies directed against carbamylated-fetal calf serum (Ca-FCS), carbamylated-fibrinogen (Ca-Fib), cyclic citrullinated-peptide 2 and IgM-RF.
RESULTS: Anti-Ca-FCS and anti-Ca-Fib antibodies were each present in 27% and 38% of the last serum samples of blood donors prior to the diagnosis of RA. Both anti-Ca-FCS and anti-Ca-Fib antibodies could be detected many years before the onset of RA. Anti-CarP antibodies as well as ACPA are, on average, detected earlier than IgM-RF.
CONCLUSIONS: In addition to ACPA and IgM-RF, also the newly identified anti-CarP antibodies appear many years before the diagnosis of RA.

Entities:  

Keywords:  Ant-CCP; Autoantibodies; Early Rheumatoid Arthritis; Rheumatoid Factor

Mesh:

Substances:

Year:  2013        PMID: 24336334     DOI: 10.1136/annrheumdis-2013-204154

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  73 in total

1.  Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.

Authors:  Alvin Yee; Tyler Webb; Andrea Seaman; Maria Infantino; Francesca Meacci; Mariangela Manfredi; Maurizio Benucci; Gabriella Lakos; Ennio Favalli; Tommaso Schioppo; Tommaso Shioppo; Pier-Luigi Meroni; Michael Mahler
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 2.  Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.

Authors:  Anca I Catrina; Kevin D Deane; Jose U Scher
Journal:  Rheumatology (Oxford)       Date:  2014-12-23       Impact factor: 7.580

Review 3.  Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis.

Authors:  Anca I Catrina; Camilla I Svensson; Vivianne Malmström; Georg Schett; Lars Klareskog
Journal:  Nat Rev Rheumatol       Date:  2016-12-15       Impact factor: 20.543

Review 4.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

5.  Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.

Authors:  Lindsay B Kelmenson; Brandie D Wagner; Bryan K McNair; Ashley Frazer-Abel; M Kristen Demoruelle; Dylan T Bergstedt; Marie L Feser; Laura K Moss; Mark C Parish; Elizabeth A Mewshaw; Ted R Mikuls; Jess D Edison; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheumatol       Date:  2019-12-26       Impact factor: 10.995

Review 6.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

Review 7.  Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention.

Authors:  Kevin D Deane
Journal:  Curr Rheumatol Rep       Date:  2018-06-26       Impact factor: 4.592

Review 8.  Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases.

Authors:  Antony Rosen; Livia Casciola-Rosen
Journal:  Annu Rev Immunol       Date:  2016-02-22       Impact factor: 28.527

Review 9.  [Treat to target and personalized medicine (precision medicine)].

Authors:  J Detert; G R Burmester
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

Review 10.  Strategies to predict rheumatoid arthritis development in at-risk populations.

Authors:  Elizabeth W Karlson; Dirkjan van Schaardenburg; Annette H van der Helm-van Mil
Journal:  Rheumatology (Oxford)       Date:  2014-08-04       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.